Selecta Biosciences INC
SEC CIK 1453687 · SELB · last insider filing 2026-04-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Kalayoglu Murat | Director | filed 2023 - 2026 |
| Singer Michael | Director | filed 2023 - 2026 |
| Brunn Carsten | Director · President and CEO | filed 2018 - 2026 |
| Springer Timothy A | Director | filed 2016 - 2026 |
| Zenner Patrick J | Director | filed 2017 - 2026 |
| Barabe Timothy C | Director | filed 2016 - 2026 |
| Desilva Nishan M | Director | filed 2021 - 2026 |
| Malik Kemal | Director | filed 2024 - 2026 |
| Bot Adrian Ion | Director | filed 2025 - 2025 |
| COX Carrie Smith | Director | filed 2019 - 2025 |
| Sallin Aymeric | Director | filed 2016 - 2024 |
| Myers Scott Dunseth | Director | filed 2019 - 2023 |
| Ando Goran | Director | filed 2020 - 2023 |
| Farokhzad Omid | Director | filed 2016 - 2019 |
| Nashat Amir | Director | filed 2016 - 2019 |
| Hutt Peter Barton | Director | filed 2016 - 2018 |
| Cautreels Werner | Director · President and CEO | filed 2016 - 2017 |
| Kania Edwin | Director | filed 2016 - 2017 |
| Isaly Samuel D | Director | filed 2016 - 2016 |
| Orbimed Advisors LLC | Director | filed 2016 - 2016 |
| Afeyan Noubar | Director | filed 2016 - 2016 |
| Gordon Carl L | Director | filed 2016 - 2016 |
| Orbimed Capital GP III LLC | Director | filed 2016 - 2016 |
| Flagship Ventures Fund 2007, L.P. | Director | filed 2016 - 2016 |
| Flagship Ventures 2007 General Partner LLC | Director | filed 2016 - 2016 |
| TAS Partners, LLC | Director | filed 2016 - 2016 |
| Leukon Investments, LP | Director | filed 2016 - 2016 |
| Shaydullina Leysan | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Davis Blaine | Chief Financial Officer | filed 2022 - 2026 |
| Miljkovic Milos | Chief Medical Officer | filed 2023 - 2026 |
| English Emily | SVP, Head of Manufacturing | filed 2024 - 2026 |
| Seymour June Ann | Chief Accounting Officer | filed 2025 - 2026 |
| Jewell Christopher M | Chief Scientific Officer | filed 2023 - 2025 |
| Kurtoglu Metin | Chief Technology Officer | filed 2023 - 2025 |
| Traber Peter G | Chief Medical Officer | filed 2020 - 2023 |
| Kishimoto Takashi Kei | Chief Scientific Officer | filed 2016 - 2023 |
| Johnston Lloyd P. | Chief Operations Officer | filed 2016 - 2023 |
| Tan Kevin | Chief Financial Officer | filed 2021 - 2022 |
| Donohue Ann K. | VP Finance | filed 2019 - 2021 |
| Dahms Bradford D. | Chief Financial Officer | filed 2019 - 2021 |
| Kogan Elona Esq. | General Counsel | filed 2019 - 2020 |
| Smolinski Stephen | Chief Commercial Officer | filed 2017 - 2020 |
| Schecter Alison D. | Chief Medical Officer | filed 2019 - 2020 |
| Leaman John Harold | CFO, Treas. & Hd Corp Strategy | filed 2017 - 2018 |
| Abraham David | GC, CCO & Corporate Secretary | filed 2016 - 2018 |
| Sands Earl | Chief Medical Officer | filed 2016 - 2017 |
| Siewers David | Chief Financial Officer | filed 2016 - 2017 |
| Keller Peter | Chief Business Officer | filed 2016 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.